What Happened?
San Diego, AB-based BioTheryX Appointed David Stirling as Chief Executive Officer
About the Company
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis through protein modulation, including protein degradation as well as multi-kinase inhibition, to develop treatments that extend and improve the quality-of-life of patients with life-threatening diseases.
About the Person
David Stirling is Chief Executive Officer at BioTheryX. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile